If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Omvoh ™ (mirikizumab-mrkz) injection
300 mg/15 mL, 100 mg/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Is there a pregnancy registry for Omvoh™ (mirikizumab-mrkz)?
An Omvoh™ (mirikizumab-mrkz) pregnancy registry will be available for healthcare providers and patients in the United States.
Mirikizumab Pregnancy Registry Information
Pregnant women exposed to mirikizumab and healthcare providers are encouraged to call Lilly at 1-800-Lilly-Rx (1-800-545-5979).
There will be a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to mirikizumab during pregnancy.
Enclosed Prescribing Information
Date of Last Review: June 08, 2023